Royal Bank of Canada Trims Stake in Synopsys, Inc. $SNPS

Posted by Francis Steltz on Jul 30th, 2026

Royal Bank of Canada lowered its position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 5.1% during the 1st quarter, HoldingsChannel reports. The firm owned 631,380 shares of the semiconductor company’s stock after selling 33,967 shares during the period. Royal Bank of Canada’s holdings in Synopsys were worth $250,330,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in SNPS. Sowell Financial Services LLC grew its position in Synopsys by 2.0% during the fourth quarter. Sowell Financial Services LLC now owns 1,056 shares of the semiconductor company’s stock worth $496,000 after buying an additional 21 shares in the last quarter. Natural Investments LLC raised its holdings in shares of Synopsys by 4.6% in the 4th quarter. Natural Investments LLC now owns 482 shares of the semiconductor company’s stock valued at $226,000 after acquiring an additional 21 shares in the last quarter. Financial Management Professionals Inc. raised its holdings in shares of Synopsys by 7.0% in the 4th quarter. Financial Management Professionals Inc. now owns 335 shares of the semiconductor company’s stock valued at $157,000 after acquiring an additional 22 shares in the last quarter. Foronjy Financial LLC boosted its position in shares of Synopsys by 5.2% during the 4th quarter. Foronjy Financial LLC now owns 446 shares of the semiconductor company’s stock valued at $210,000 after acquiring an additional 22 shares during the last quarter. Finally, AGH Wealth Advisors LLC boosted its position in shares of Synopsys by 4.4% during the 1st quarter. AGH Wealth Advisors LLC now owns 569 shares of the semiconductor company’s stock valued at $226,000 after acquiring an additional 24 shares during the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Key Headlines Impacting Synopsys

Here are the key news stories impacting Synopsys this week:

Positive Sentiment: Expanded Nvidia partnership supports AI growth. Nvidia is adding Synopsys to its Agent Toolkit ecosystem, helping automate chip and system design. The relationship could increase demand for Synopsys’ electronic design automation (EDA) software as semiconductor companies adopt agentic AI. Agentic AI Is Coming to Chip Design. Here Is Why Synopsys Stock Could Be the Biggest Beneficiary
Positive Sentiment: AI alliances may strengthen Synopsys’ strategic position. Partnerships involving Nvidia, AMD, Microsoft and Intel are aimed at automating chip-design bottlenecks, potentially improving productivity for customers and reinforcing Synopsys’ central role in the semiconductor ecosystem. Synopsys Just Solved a Bottleneck You Didn’t Even Know Existed
Positive Sentiment: Intel’s next-generation 14A process provides another validation point. Synopsys’ tools are already supporting Intel’s 14A chip-development efforts, highlighting the importance of its software in advanced semiconductor manufacturing. Intel’s 14A chips aren’t built yet: Synopsys is already there
Neutral Sentiment: Recent results remain solid but acquisition-driven. Quarterly revenue rose 41.9% year over year to $2.28 billion and EPS exceeded expectations, largely reflecting the Ansys acquisition. Investors may be looking for stronger organic growth to support Synopsys’ premium valuation. Synopsys: How Agentic AI And Ansys Drive Long-Term Growth
Negative Sentiment: The immediate decline appears tied more to market and valuation pressure than a new fundamental setback. Reports noted that Synopsys underperformed the broader market during the latest session, while its elevated earnings multiple and recent underperformance likely encouraged caution and profit-taking. No new earnings warning was cited. Here’s Why Synopsys Fell More Than Broader Market

Insider Activity at Synopsys

In related news, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the transaction, the chief financial officer owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the transaction, the chief executive officer directly owned 75,020 shares in the company, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Company insiders own 0.56% of the company’s stock.

Analyst Ratings Changes

SNPS has been the subject of several recent analyst reports. Morgan Stanley boosted their price objective on Synopsys from $480.00 to $525.00 and gave the stock an “equal weight” rating in a report on Thursday, May 28th. KeyCorp reiterated an “overweight” rating on shares of Synopsys in a research report on Thursday, May 28th. Needham & Company LLC reiterated a “buy” rating and set a $580.00 target price on shares of Synopsys in a research report on Thursday, May 28th. Piper Sandler raised shares of Synopsys from a “neutral” rating to an “overweight” rating and boosted their price target for the stock from $450.00 to $550.00 in a research note on Tuesday, June 23rd. Finally, BNP Paribas Exane increased their price target on shares of Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a report on Thursday, May 28th. Two research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Synopsys currently has a consensus rating of “Moderate Buy” and a consensus price target of $570.06.

Check Out Our Latest Stock Report on SNPS

Synopsys Price Performance

Shares of Synopsys stock opened at $373.69 on Thursday. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $71.55 billion, a PE ratio of 86.50, a price-to-earnings-growth ratio of 2.25 and a beta of 1.22. The business’s 50-day moving average price is $449.23 and its 200-day moving average price is $452.19. Synopsys, Inc. has a 12 month low of $366.00 and a 12 month high of $651.73.

Synopsys (NASDAQ:SNPS – Get Free Report) last released its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, topping analysts’ consensus estimates of $3.15 by $0.20. The company had revenue of $2.28 billion during the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.Synopsys’s quarterly revenue was up 41.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Sell-side analysts forecast that Synopsys, Inc. will post 10.65 EPS for the current fiscal year.

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.